The expression of CD44 isoforms within the tumour impacts key features of cancer cells such as tumourigenicity, tumour initiating potential, metastasis, chemo and/or radio-resistance, etc. Some researchers concluded that tumours expressing particular isoforms of CD44v are more aggressive compared to tumours expressing CD44s only. The gene discussed is CD44; the disease is cancer.